G. Barger

发表

Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.

E. Shaw, Meihua Wang, S. Coons, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility of Multimodal MRI-Based Deep Learning Prediction of High Amino Acid Uptake Regions and Survival in Patients With Glioblastoma

G. Barger, S. Mittal, Jeong-Won Jeong, 2019, Front. Neurol..

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Walter J. Curran, Mark R. Gilbert, Jean-Paul Bahary, 2016, The New England journal of medicine.

History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.

K. Aldape, G. Barger, K. Kelsey, 2005, American journal of epidemiology.

Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI

G. Barger, S. Mittal, C. Juhász, 2015, Journal of Neuro-Oncology.

In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors.

G. Barger, O. Muzik, H. Chugani, 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

G. Barger, S. Reingold, C. Bever, 2000, Multiple sclerosis.

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies

G. Barger, S. Mittal, A. Thakur, 2013, BMC Cancer.

Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma

G. Barger, S. Mittal, C. Juhász, 2017, Clinical nuclear medicine.

Prevalence of antibodies to four herpesviruses among adults with glioma and controls.

G. Barger, K. Kelsey, R. Miike, 2001, American journal of epidemiology.

Reduced Immunoglobulin E and Allergy among Adults with Glioma Compared with Controls

G. Barger, M. Moghadassi, R. Miike, 2004, Cancer Research.

Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates

G. Barger, O. Muzik, S. Mittal, 2013, Journal of Neuro-Oncology.

ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG).

E. Shaw, W. Curran, S. Coons, 2015 .

AT-13R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE

E. Shaw, W. Curran, S. Coons, 2014 .

Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG.

E. Shaw, W. Curran, S. Coons, 2014 .

In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.

G. Barger, L. Rorke, B. Zweiman, 1980, Cellular immunology.

Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT + procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG)

E. Shaw, Meihua Wang, D. Brachman, 2008 .

Phase II study of hydroxyurea for unresectable meningioma (Southwest Oncology Group S9811).

G. Barger, C. Rankin, E. Rushing, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial report of Radiation Therapy Oncology Group (RTOG) 9802: Prospective studies in adult low-grade glioma (LGG).

E. Shaw, S. Coons, D. Brachman, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Glioblastoma metastatic to the ovary, a very different Krukenberg tumor?

G. Barger, M. Dominello, W. Kupsky, 2018, Practical radiation oncology.

Recurrent Strongyloides stercoralis hyperinfection syndrome: Case report and a brief review

G. Barger, P. Chandrasekar, S. Krishnan, 2006 .

Recurrent Strongyloides stercoralis Hyperinfection Syndrome

G. Barger, S. Krishnan, 2006 .

Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma

G. Barger, W. Wara, V. Levin, 1983, Cancer.

Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls.

R Miike, G. Barger, J. Neuhaus, 1997, American journal of epidemiology.

Accurate Differentiation of Recurrent Gliomas from Radiation Injury by Kinetic Analysis of α-11C-Methyl-l-Tryptophan PET

Otto Muzik, Csaba Juhász, Sandeep Mittal, 2012, The Journal of Nuclear Medicine.

Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential.

G. Barger, N. de Tribolet, C. Wilson, 1983, Journal of neurosurgery.

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813

Susan M. Chang, K. Aldape, D. Brachman, 2016, Neuro-oncology.

In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas

G. Barger, A. Sloan, S. Brem, 2006, Clinical Cancer Research.

GBM-associated mutations and altered protein expression are more common in young patients

R. Verhaak, G. Barger, S. Kesari, 2016, Oncotarget.

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

K. Aldape, E. Shaw, D. Brachman, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gliosarcoma with multiple extracranial metastases: case report and review of the literature

G. Barger, A. Sloan, W. Kupsky, 2007, Journal of Neuro-Oncology.

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.

E. Shaw, D. Brachman, J. Buckner, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central diabetes insipidus and adipsia due to astrocytoma: diagnosis and management

G. Barger, N. Rossi, Imad Modawi, 2013, CEN Case Reports.

Discrepancies in diagnoses of neuroepithelial neoplasms

G. Barger, R. Miike, M. Wrensch, 2000, Cancer.

Imaging Correlates of Differential Expression of Indoleamine 2,3-Dioxygenase in Human Brain Tumors

G. Barger, O. Muzik, H. Chugani, 2009, Molecular Imaging and Biology.

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial.

E. Shaw, S. Coons, D. Brachman, 2008, Journal of neurosurgery.

Multimodal Imaging of Nonenhancing Glioblastoma Regions

G. Barger, S. Mittal, C. Juhász, 2019, Molecular imaging.

Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.

G. Barger, S. Pannullo, S. Mittal, 2017, Journal of neurosurgery.

Differentiation of Glioblastomas from Metastatic Brain Tumors by Tryptophan Uptake and Kinetic Analysis: A Positron Emission Tomographic Study with Magnetic Resonance Imaging Comparison

Otto Muzik, Csaba Juhász, Sandeep Mittal, 2013, Molecular imaging.

Depression and tryptophan metabolism in patients with primary brain tumors: Clinical and molecular imaging correlates

G. Barger, S. Mittal, S. Michelhaugh, 2020, Brain Imaging and Behavior.

Depression and tryptophan metabolism in patients with primary brain tumors: Clinical and molecular imaging correlates

G. Barger, S. Mittal, C. Juhász, 2020, Brain Imaging and Behavior.

Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival

Csaba Juhász, Sandeep Mittal, G. Barger, 2018, Neuro-oncology.

Clinical Significance of Tryptophan Metabolism in the Nontumoral Hemisphere in Patients with Malignant Glioma

G. Barger, O. Muzik, S. Mittal, 2014, The Journal of Nuclear Medicine.

Low-grade gliomas in adults

G. Barger, S. Mittal, Mark C Szlaczky, 2008, Current treatment options in neurology.

Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes.

G. Barger, L. Zamorano, F. Diaz, 2000, Neurosurgical focus.

Differential kinetics of α-[11C]methyl-l-tryptophan on PET in low-grade brain tumors

G. Barger, O. Muzik, H. Chugani, 2011, Journal of Neuro-Oncology.

Response of Human Malignant Gliomas and CNS Tissue to 125I Brachytherapy: A Study of Seven Autopsy Cases

G. Barger, P. Gutin, T. Phillips, 1984 .

Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)

G. Barger, M. Gilbert, M. Mehta, 2016, American journal of clinical oncology.

Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma.

G. Barger, O. Muzik, S. Mittal, 2014, Neuro-oncology.

Charles B. Wilson, G. Barger, R. Davis, 1982, The Lancet.

Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors.

Susan M. Chang, W. Curran, J. Buckner, 2004, International journal of radiation oncology, biology, physics.

Author's response to reviews Title: Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies Authors:

G. Barger, L. Lum, 2013 .

In Vivo Uptake and Metabolism of α-[11C]Methyl-l-Tryptophan in Human Brain Tumors

G. Barger, O. Muzik, H. Chugani, 2006 .

Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma.

G. Barger, S. Mittal, C. Juhász, 2017, Clinical nuclear medicine.

Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas

G. Barger, D. Chugani, S. Mittal, 2015, Cancer Imaging.

Familial factors associated with malignant gliomas

G. Barger, D. Rao, M. Wrensch, 1990, Genetic epidemiology.

ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS

K. Aldape, E. Shaw, S. Coons, 2017 .

Does prior infection with varicella-zoster virus influence risk of adult glioma?

G. Barger, R. Miike, M. Wrensch, 1997, American journal of epidemiology.

NIMG-37IMAGING CEREBRAL TRYPTOPHAN METABOLISM IN BRAIN TUMOR-ASSOCIATED DEPRESSION.

G. Barger, M. Behen, S. Mittal, 2015 .

Imaging cerebral tryptophan metabolism in brain tumor-associated depression

G. Barger, M. Behen, S. Mittal, 2015, EJNMMI Research.

NIMG-38MULTIMODAL IMAGING OF SPATIAL PATTERNS OF POST-TREATMENT GLIOBLASTOMA PROGRESSION

G. Barger, S. Mittal, C. Juhász, 2015 .

Quantitative PET Imaging of Tryptophan Accumulation in Gliomas and Remote Cortex: Correlation With Tumor Proliferative Activity

G. Barger, O. Muzik, D. Chugani, 2012, Clinical nuclear medicine.

Cell-based assays using primary endothelial cells to study multiple steps in inflammation.

J. Rothman, G. Barger, B. Jagla, 2006, Methods in enzymology.

Brain tumor committee

W. Yung, M. Prados, G. Barger, 2001 .

ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA)

Susan M. Chang, K. Aldape, D. Brachman, 2015 .

Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA).

Susan M. Chang, K. Aldape, D. Brachman, 2015 .